-
Applied Workflows with 3X (DYKDDDDK) Peptide for FLAG Tag Pu
2026-06-15
The 3X (DYKDDDDK) Peptide elevates recombinant protein workflows, enabling ultra-sensitive affinity purification and robust detection—even for challenging targets like membrane proteins. Its trimeric design delivers reproducible results in both routine and advanced applications, from metal-dependent ELISA assays to protein crystallization.
-
Single-Molecule Insights into Replication Fork and R-Loop Co
2026-06-15
This study offers the first direct single-molecule visualization of DNA replication fork collisions with R-loops, revealing how R-loop positioning and secondary structures impede replication. These findings clarify the molecular mechanisms linking R-loop accumulation to replication stress and genome instability, providing a foundation for future mechanistic and methodological advances.
-
E-4031: hERG Potassium Channel Blocker in Cardiac Electrophy
2026-06-14
E-4031 is the gold-standard hERG potassium channel blocker for modeling proarrhythmic risk and QT interval prolongation in cardiac electrophysiology research. This guide details experimental workflows, advanced use-cases, and troubleshooting strategies that maximize the value of E-4031 from APExBIO, with actionable insights rooted in both foundational and cutting-edge literature.
-
Amikacin Sulfate: Precision Pharmacology for Granuloma-Targe
2026-06-13
Explore the advanced pharmacology of Amikacin Sulfate, focusing on its unique intracellular delivery, granuloma targeting, and safety profile. This article reveals new insights for researchers optimizing antibiotic strategies against non-tuberculous mycobacterial infections.
-
PLGA-Based Nano-Adjuvant Boosts Chick Mucosal Immunity to H9
2026-06-12
A novel PLGA-based nano-adjuvant (PEI-LSP-RA-PLGA) was developed to enhance both mucosal and systemic immune responses to H9N2 avian influenza vaccination in chicks. By enabling targeted intestinal delivery and robust IgA production, this strategy addresses longstanding challenges in achieving effective mucosal immunity with conventional vaccines.
-
Dutasteride: Molecular Precision for Apoptosis and Prostate
2026-06-12
Explore how Dutasteride, a dual 5-alpha-reductase inhibitor, enables advanced apoptosis and androgen pathway studies in prostate cancer and BPH research. This article uniquely bridges molecular mechanisms with practical protocol guidance and assay reliability.
-
Technical Use of EdU Imaging Kits (Cy5) for S-Phase DNA Anal
2026-06-11
EdU Imaging Kits (Cy5) provide a robust alternative to BrdU assays for quantifying cell cycle S-phase DNA synthesis, especially where high sensitivity and minimal sample disruption are essential. These kits streamline fluorescence-based detection without harsh denaturation steps, but are not suitable for applications requiring live-cell tracking or multiplexing beyond the specified fluor channels.
-
Phosphoenolpyruvate Restricts cGAS-STING Inflammation in Agi
2026-06-11
A recent study highlights phosphoenolpyruvate (PEP), a glycolytic metabolite, as an endogenous inhibitor of the cGAS–STING inflammatory pathway, thereby promoting healthy aging by mitigating chronic inflammation. This mechanistic insight reveals new therapeutic directions for age-related diseases and underscores the centrality of metabolic intermediates in regulating inflammation.
-
EdU Imaging Kits (HF594): Practical Guide for DNA Synthesis
2026-06-10
EdU Imaging Kits (HF594) enable direct, sensitive detection of DNA synthesis for cell proliferation assays, overcoming the need for harsh denaturation and antibody staining required by BrdU methods. The kit is ideal for fixed-cell applications using fluorescence microscopy or flow cytometry, but is not suitable for live-cell imaging or for detecting non-S-phase events.
-
Ferrostatin-1 (Fer-1): Reliable Ferroptosis Inhibition in Ce
2026-06-10
This article explores real-world laboratory challenges in ferroptosis research and demonstrates how Ferrostatin-1 (Fer-1, SKU A4371) addresses issues of reproducibility, selectivity, and workflow optimization in cell viability and cytotoxicity assays. Practical Q&A scenarios grounded in recent literature and validated protocols highlight the scientific and operational advantages of selecting APExBIO's Ferrostatin-1 (Fer-1) for advanced biomedical research.
-
Bufalin: Cardiotoic Steroid Transforming Cancer Cell Workflo
2026-06-09
Bufalin, a potent cardiotonic steroid from APExBIO, enables precise apoptosis induction and molecular target degradation in triple-negative breast cancer and hepatocellular carcinoma models. This article delivers actionable workflows, advanced troubleshooting, and protocol enhancements to maximize reproducibility and scientific insight at the bench.
-
Homoharringtonine (SKU N1504): Reliable Solutions for Cytoto
2026-06-09
This article provides practical, scenario-driven guidance for using Homoharringtonine (SKU N1504) in cell viability, proliferation, and SARS-CoV-2 antiviral assays. Drawing on current literature and real laboratory challenges, it explains how this cytotoxic alkaloid ensures reproducibility and sensitivity in advanced cancer and viral research workflows.
-
20-HETE–TRPV1–MrgprA3+ Axis Drives Allokinesis in Chronic De
2026-06-08
This study elucidates how elevated 20-HETE mediates TRPV1 activation on MrgprA3+ sensory neurons, driving itch (allokinesis) in chronic dermatitis. The findings clarify the molecular interface between itch and pain in inflamed skin and highlight new avenues for targeted intervention.
-
MOG (35-55) Peptide: Elevating Autoimmune Encephalomyelitis
2026-06-08
MOG (35-55) Peptide enables precise, reproducible modeling of autoimmune neuroinflammation, empowering advanced multiple sclerosis research. This guide details optimized workflows, troubleshooting strategies, and actionable insights from cutting-edge literature for robust EAE induction and analysis.
-
CSRP2 Regulates PRC1-Mediated PDGFRA/PI3K/AKT in Glioma
2026-06-07
The study uncovers CSRP2 as a mesenchymal glioma-enriched protein that modulates PDGFRA/PI3K/AKT signaling through PRC1 chromatin regulation, impacting tumor growth and aggressiveness. These findings refine the understanding of glioma epigenetics and suggest CSRP2 as a context-dependent biomarker.